Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
The use of telemedicine in patients with multiple sclerosis.
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Sodium channel Nav1.8: Emerging links to human disease.
Drugs in Development for Relapsing Multiple Sclerosis.
Negotiating the radiologically isolated syndrome.
A dam for retrograde axonal degeneration in multiple sclerosis?
Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.
Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Obtaining from Grape Pomace an Enzymatic Extract with Anti-inflammatory Properties.
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled
Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication.
Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: A case report.
[Optical coherence tomography in neuro-ophthalmology].
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
Myelination: Do Astrocytes Play a Role?
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Pages
« first
‹ previous
…
305
306
307
308
309
310
311
312
313
…
next ›
last »